Moneycontrol PRO
HomeNewsEmergency use listing

Emergency Use Listing

Jump to
  • Why did the WHO suspend supply of Covaxin?

  • In-Depth | Travel plans of many still in limbo as some nations haven't accepted Covaxin despite WHO nod

    In-Depth | Travel plans of many still in limbo as some nations haven't accepted Covaxin despite WHO nod

    With the EUL status accorded by the WHO, more countries are expected to add Covaxin to the list of recognised vaccines. But until then, many Indians with overseas travel plans are left in the lurch.

  • COVID-19 vaccine | Bharat Biotech has been submitting data regularly, very quickly: WHO on Covaxin EUL

    COVID-19 vaccine | Bharat Biotech has been submitting data regularly, very quickly: WHO on Covaxin EUL

    The World Health Organization said on emergency use listing (EUL) of Covaxin: "... We are right now at the last stage of the assessment by this external advisory group, and we hope to have a final recommendation to the WHO next week. I hope that is well understood.”

  • COVID-19 vaccine | 'If all goes well' Covaxin to get WHO nod within 24 hours

    COVID-19 vaccine | 'If all goes well' Covaxin to get WHO nod within 24 hours

    Its technical advisory group is reviewing data on Covaxin and 'if all is in place', a recommendation could come in within 24 hours or so, a WHO spokesperson has said

  • COVID vaccine EUL recommendation process sometimes takes longer: WHO official says as Covaxin decision awaited

    COVID vaccine EUL recommendation process sometimes takes longer: WHO official says as Covaxin decision awaited

    The World Health Organisation is very clear that we want all countries to recognise vaccines that have been given an Emergency Use Listing (EUL) by the WHO advisory process.

  • WHO to give final judgement on Covaxin emergency use listing next week

    WHO to give final judgement on Covaxin emergency use listing next week

    Bharat Biotech, the producer of Covaxin has presented data to WHO on a rolling basis and submitted additional info at WHO’s request on September 27.

  • COVID-19 vaccine | Novovax, Serum Institute seek WHO emergency use nod for Covovax

    COVID-19 vaccine | Novovax, Serum Institute seek WHO emergency use nod for Covovax

    The submission to WHO is based on Novovax, SII’s previous regulatory submission to the Drug Controller General of India (DGCI) in August 2021 seeking emergency use nod for its protein-based coronavirus vaccine Covovax in India.

  • Govt expects Covaxin to get emergency use approval from WHO in next 2-3 months

    Govt expects Covaxin to get emergency use approval from WHO in next 2-3 months

    Covaxin manufacturer Bharat Biotech International Limited submitted the data required for global emergency use approval to the World Health Organization on July 9.

  • WHO vaccine list | People vaccinated with Covaxin may not be allowed to travel abroad: Report

    WHO vaccine list | People vaccinated with Covaxin may not be allowed to travel abroad: Report

    Based on data collected from covid19.trackvaccines.org, less than 10 nations have officially approved the Covaxin while most countries only recognise Covishield as the required vaccine for passengers coming from India.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347